Selective and rapid uptake of adeno-associated virus type 2 in brain.
about
Biology of adeno-associated viral vectors in the central nervous systemA novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cellsGene therapy in Parkinson's disease: rationale and current statusControlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveRecombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microgliaCRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent InfectionsConditional, genetic disruption of ciliary neurotrophic factor receptors reveals a role in adult motor neuron survivalMethods, potentials, and limitations of gene delivery to regenerate central nervous system cellsPTEN knockdown alters dendritic spine/protrusion morphology, not densityIntrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.Rapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors.Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens.Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferMolecular evolution of adeno-associated virus for enhanced glial gene delivery.Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brainsEndocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.Adeno-associated virus vectors and hematologyAdeno-associated viral vectors for gene transfer and gene therapy.Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primatesImpaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts.Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport.Repeated delivery of adeno-associated virus vectors to the rabbit airway.Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.Gene therapy in the CNS.Adeno-associated virus effectively mediates conditional gene modification in the brainFrom gene transfer to gene therapy in lysosomal storage diseases affecting the central nervous system.Pathology associated with AAV mediated expression of beta amyloid or C100 in adult mouse hippocampus and cerebellumIntravitreal injection of AAV2 transduces macaque inner retinaRecombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.Angiotensin II type 1a receptors in subfornical organ contribute towards chronic intermittent hypoxia-associated sustained increase in mean arterial pressure.The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivityEnhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variantIntracellular transport of recombinant adeno-associated virus vectors.Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.Adeno-associated virus vectors: potential applications for cancer gene therapy.
P2860
Q21129328-55C5A18E-FF0C-4089-AE68-2D4C972058CFQ21142728-9076617A-1F0A-4EE6-925A-270F2D8662A1Q22241423-DB57E9AB-D42D-4194-9BF6-6C230B5CF5A0Q24796221-5705360E-A11A-4206-9B9C-27D5B4A1AEAAQ27007782-9C668930-8894-491C-A01C-7104574B1003Q27012320-419AC133-5A12-4C4E-8A2E-DA52573AC1DFQ28386583-5252CBB9-D81A-4535-B862-FE415E11E40CQ28552274-78388F96-49B0-4293-A597-FD4774717636Q28591327-EA0BDD9B-B66F-441D-B30A-28662EBB5858Q28766660-4D294B05-A02F-438A-A4BE-889C049B3E42Q30415350-26F4CEE7-9B49-45FA-90AB-FFA123F6890DQ30493159-04553129-2A8C-42CF-8025-2F32EE79C0DEQ30495536-C868B109-FA3C-4BDC-B9C7-DF44F9E16B46Q30497984-95D3067F-ADF8-4828-BB06-58781FDD3207Q30505116-7D84B8C2-0F09-4DEB-9ED3-BF920582B951Q33296224-D8747CFC-87B0-4EFB-A492-E269F19F4650Q33492733-3BBE45DC-091B-46F7-8D15-2A41DB3D234DQ33577391-0227CC11-9269-404D-89E1-6129D946C7D8Q33604753-489C4EDC-16C6-43B5-A0E6-CC833BB37B86Q33695816-A02444BD-6D95-48AB-B66C-438EFD72077CQ33701559-7A21772E-2E9B-4FB1-A282-53AE76C438BDQ33713108-B9693388-2371-4FC4-92F3-E6F839759390Q33731243-08EA0108-4094-4CE1-A068-CD05EC033DB6Q33796712-20FF63E7-869D-42AE-A07B-93E33EE25D35Q33805013-443AB766-CFC0-43F4-9DD8-59932A08F65BQ33823405-52484173-6D1F-48A4-B3AB-B1D179E91082Q33827255-DC991BC1-6EC6-4653-BF42-74C645362EB6Q33837123-54D0C3BD-7586-4182-9959-E1E9FDF3D0D1Q34013197-784D88C1-803D-4820-B553-9F7FF89218E5Q34224260-CEA0EC51-9D8F-4F12-A2D9-3065298C7BE8Q34630346-E33D5183-9DA7-48E9-864F-5969153AED08Q34937075-2A741F06-FD19-4381-A520-15FB1864EED5Q35111738-1AD234B5-C647-4A13-B591-93526150B4BCQ35138604-D8204AF1-4F04-401E-8887-5E1D86718A0BQ35341751-9400F62B-A057-4F28-9B88-712B6168A3C4Q35542643-4C4A7566-4020-4CA4-9588-BF52CBA4740EQ35635046-FDE26F94-19B6-4FFD-AE94-4E6FF26C6F45Q35734826-00015CBC-B473-4535-B77D-25AF825C71A6Q35853990-0A9EABBE-3BDB-451E-B643-C4ECEC53B4C6Q36165834-4BA19507-6C4A-4E74-9550-05FA7D6A0823
P2860
Selective and rapid uptake of adeno-associated virus type 2 in brain.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@ast
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@en
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@nl
type
label
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@ast
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@en
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@nl
prefLabel
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@ast
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@en
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@nl
P2093
P1433
P1476
Selective and rapid uptake of adeno-associated virus type 2 in brain.
@en
P2093
Bartlett JS
Samulski RJ
P304
P356
10.1089/HUM.1998.9.8-1181
P577
1998-05-01T00:00:00Z